If you were to invest $25,000 into each of the stocks below, you could earn an additional $8,665 this year.

NEW YORK, NY / ACCESS Newswire / May 30, 2025 / If you suffered a loss on your Strategy Incorporated (NASDAQ:MSTR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/strategy-incorporated-lawsuit-submission-form?prid=150999&wire=1&utm_campaign=9 or contact Joseph E. Levi, Esq.

Liz Ann Sonders, chief investment strategist at Charles Schwab, joins CNBC's 'Squawk on the Street' to discuss outlooks on markets, how to position, and more.

Gap Inc (NYSE:GAP) stock is freefalling, last seen down 19.7% to trade at $22.49, after the apparel retailer issued lackluster current-quarter guidance.

Howmet Aerospace Inc. (NYSE:HWM ) Bernstein 41st Annual Strategic Decisions Conference May 30, 2025 8:00 AM ET Company Participants John Plant - Executive Chairman and Chief Executive Officer Conference Call Participants Douglas Harned - Bernstein Douglas Harned Hey, good morning, everybody. Why don't we get started?

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX ) Bernstein 41st Annual Strategic Decisions Conference May 30, 2025 8:00 AM ET Company Participants Reshma Kewalramani - President & CEO Conference Call Participants Will Pickering - Bernstein Will Pickering All right. Well, I think we can get started.

WARREN, N.J., May 30, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today provided stockholders with a detailed overview of its artificial intelligence initiative, Tevogen.AI™.

The average of price targets set by Wall Street analysts indicates a potential upside of 29.1% in Pan American Silver (PAAS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

The average of price targets set by Wall Street analysts indicates a potential upside of 28.6% in Pagaya Technologies Ltd. (PGY). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

The average of price targets set by Wall Street analysts indicates a potential upside of 25.2% in Nexxen International Ltd. Sponsored ADR (NEXN).

The average of price targets set by Wall Street analysts indicates a potential upside of 32.1% in Janus International Group (JBI). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

The mean of analysts' price targets for Xperi (XPER) points to a 134.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

LMT secures $509M Air Force contract to build GPS III satellites with advanced anti-jamming technology, boosting its space and defense leadership.

Although the Zacks Auto Equipment industry is unfavorably ranked currently, stocks like ALSN, STRT and LAZR are worth considering now.

URA, DAPP, NIKL, BCOR and CHAT topped sector ETF gains in May, riding a broad market rebound on easing tariffs and strong tech earnings.

MRX, BIRK and DB made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on May 30, 2025.

How much is Google Chrome worth to Alphabet (GOOGL)? That's a question Kevin Green weighs when looking at Alphabet's valuation if the company is forced to divest its Chrome search browser.

NEW YORK, NY / ACCESS Newswire / May 30, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of UroGen Pharma Ltd. ("UroGen Pharma Ltd.

NEW YORK, NY / ACCESS Newswire / May 30, 2025 / If you suffered a loss on your DoubleVerify Holdings, Inc. (NYSE:DV) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/doubleverify-holdings-inc-lawsuit-submission-form-2?prid=150994&wire=1&utm_campaign=16 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 30, 2025 / If you suffered a loss on your Zenas BioPharma, Inc. (NASDAQ:ZBIO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/zenas-biopharma-inc-lawsuit-submission-form?prid=150995&wire=1&utm_campaign=25 or contact Joseph E. Levi, Esq.